Another key feature of CallAssure is that the survey is dynamic. Based on the medication and the patient's responses to questions, the survey script will trigger an email notification immediately to a physician for follow-up.
"Previously, information about symptoms and side effects was not collected in a standard and thorough manner," says Iyer. "Now, we are able to test a method that closes that follow-up loop and provides real-time reporting for review and analysis.
"We look forward to exploring potential ways to improve patient safety with new technology, and are happy to be working with the Vocantas team on this project."
About Vocantas
Vocantas is a developer of interactive voice response systems (IVRS) that use advanced computer telephony and speech technology to provide its customers with cost-effective customer outreach solutions. The company's easy-to-use, turn-key solutions offer customizable core features and optional enhancements that integrate seamlessly with existing systems. Its products have particular application in the healthcare, utilities and customer service environments where they have been proven to increase efficiencies while minimizing operational costs. For more information, please visit www.vocantas.com
"CallAssure" is a trademark of Vocantas Inc. The names of other companies
or products mentioned herein may be the trademarks of their respective
owners.
| SOURCE VOCANTAS Copyright©2008 PR Newswire. All rights reserved |